
bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

Azeria Therapeutics bags €37.3m in Series B financing round
Series A lead investor CRT Pioneer Fund co-financed the Series B financing round. Azeria said it will use the proceeds to develop its preclinical...

Novo secures Dicerna’s RNAi liver assets
Under the deal, which includes potential treatments for NASH, orphan liver diseases, obesity and diabetes, Dicerna could theoretically earn...

GeNeuro and Karolinska Institute collaborate in multiple sclerosis
The 12-months trial, which will kick-off in QI/2020, will be led by Dr. Fredrik Piehl, head of research at the MS clinic at ASC in Stockholm, which...

Polyphor presents AMR breaker
In Nature, Anatol Luther et al. from Polyphor AG and the University of Zurich describe the discovery and characterisation of a new class of...

ADC Therapeutics set to go public
The number of shares to be offered and the price range for the proposed offering have still to be determined. Despite an internal review conducted...

Rotavirus vaccines kill cancer cells
The team headed by Aurelian Marabelle discovered in mice that commercially available vaccines against rotavirus – which causes diarrhea in children...